We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




2013 Online Pathology Progress Test Now Available

By LabMedica International staff writers
Posted on 17 Dec 2013
Print article
The 2013 version of the main exam for progress monitoring and for evaluating and establishing training standards in pathology across Europe is now available.

As of November 25, the 2013 EUROPALS annual pathology test is now available, offered by the European Society of Pathology (ESP) in close collaboration with the European Association of Pathology Chairs & Program Directors (EAPCP). The 2013 test coordinator is Prof. Dr. Fred T. Bosman. It is especially intended for trainees but all ESP member pathologists are free to participate.

The test consists of 100 questions, partly straight, multiple choice questions, partly still-image based and partly virtual-slide based, and extended matching questions. The chosen level is that of a trainee at the end of a residency program. The test comprises of questions with a purely diagnostic orientation, molecular pathology test items, and mechanism of disease-oriented questions.

The test is preferably to be done in one run but can be done in parts if needed. It generally takes approximately 2–2.5 hours in total. A score result will be provided to the test-taker immediately upon completion of the exam. The test is formative—a tool for self-assessment. The results are kept anonymous.

The exam can be taken by logging on to the online (please see Related Links below) with one’s own password; for those without a password, one can be obtained on the website. All existing users are requested to update their Year of Training and Country from “My Account -> Your Details” once logged into PathXL.

Please note prior to taking the test that it is highly recommended to upgrade to the latest versions of Internet Explorer (v9 or v10), Firefox (v24), Google Chrome (v30) or Safari (v5.1.7) for optimal performance and experience. Problems may be experienced using unsupported browsers, such as older versions of Internet Explorer. Tablets or mobile devices are not supported for the test.

Related Links:

European Society of Pathology
Pathxl
EUROPALS Annual Pathology Test


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Liquid Based Cytology Production Machine
LBP-4032
New
Nuclear Matrix Protein 22 Test
NMP22 Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.